| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 10/02/2008 | CA2682163A1 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments |
| 10/02/2008 | CA2681545A1 Fluorinated derivatives of deferiprone |
| 10/02/2008 | CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure |
| 10/01/2008 | EP1975161A1 Heterocyclyl-substituted- tetrahydro-napthalen-amine derivatives, their preparation and use as medicaments |
| 10/01/2008 | EP1973902A2 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
| 10/01/2008 | EP1973881A2 6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides |
| 10/01/2008 | EP1973880A1 Piperazinyl derivatives as modulators of chemokine receptor activity |
| 10/01/2008 | EP1973879A2 Process for preparing imino compounds |
| 10/01/2008 | EP1973404A1 Malononitrile compounds |
| 10/01/2008 | EP1841739A4 Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon2-yl)methyl] piperidine or its salt thereof via novel intermediate |
| 10/01/2008 | EP1572652B1 Process for preparing pyridinium fluorochromate (vi) |
| 10/01/2008 | CN100422153C N-(2-substituted phenyl)-N-methoxy carbamate compounds and their preparation and use |
| 10/01/2008 | CN100422152C Pyridyl quinone derivative material and its preparing method |
| 10/01/2008 | CN100422147C Method of preparing compound of 0-substituted sulphonyl propylhomoserin class |
| 10/01/2008 | CN100422129C Production process of optically pure 2- (4-hydroxyphenoxy) - propionic acid compounds |
| 09/30/2008 | US7429677 3'-methylene-bis(6-((4-methylphenyl)sulfonylamino)-benzoic acid) , or its N-oxide form, salt, stereoisomeric form, racemic mixture, prodrug or ester; block HIV from entering the human cell by interfering with various phases of attachment and fusion between HIV and the cell; Anti HIV agent; AIDS |
| 09/30/2008 | US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 09/30/2008 | US7429604 Six-membered heterocycles useful as serine protease inhibitors |
| 09/30/2008 | US7429603 C-fms kinase inhibitors |
| 09/30/2008 | US7429593 Utilities of amide compounds |
| 09/30/2008 | US7429587 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 09/30/2008 | US7429586 Non-imidazole aryloxyalkylamines |
| 09/30/2008 | US7429278 N-(2-Thiophen-2-ylethyl)benzene-1,4-diamine; hair dye; very strong and sparingly selective coloration of keratin fibers, light fast, avoiding the degradation of the fibers |
| 09/30/2008 | CA2381001C Carbamate derivative and agricultural/horticultural fungicide |
| 09/30/2008 | CA2303848C Substituted anilides |
| 09/28/2008 | CA2627529A1 Fluorinated derivatives of deferiprone |
| 09/25/2008 | WO2008115369A2 Inhibitors of focal adhesion kinase |
| 09/25/2008 | WO2008115281A2 Compounds for treating viral infections |
| 09/25/2008 | WO2008114886A1 Dye compound, yellow toner, thermal transfer recording sheet, and ink |
| 09/25/2008 | WO2008114831A1 Antibacterial agent having sulfonamide group |
| 09/25/2008 | WO2008114275A2 Anthranilic acid derivatives as anticancer agents and process for the preparation thereof |
| 09/25/2008 | WO2008113835A1 Process for preparing (r or s)-5-{1-azido-3-[6-methoxy-5-(3-methoxy-propoxy)-pyridin-3-ylmethyl]-4-methyl-pentyl}-3-alkyl-dihydro-furan-2-one |
| 09/25/2008 | WO2008113255A1 Benzamide derivatives with anti-proliferative activity, pharmaceutical preparations thereof |
| 09/25/2008 | WO2008091681A3 Theramutein modulators |
| 09/25/2008 | WO2008024953A3 Transition metal-catalyzed alkylation of c-h bonds with organoboron reagents |
| 09/25/2008 | US20080234488 Using Group 8, or compound thereof, as catalyst; deuteration a compound containing aromatic or heterocyclic ring |
| 09/25/2008 | US20080234335 2-Cyclohexenyl-1-carboxylic acid derivatives, e.g., 6-[2-(5-chloro-2-{[(4-fluorophenyl)methyl]oxy}phenyl)-1-cyclohexen-1-yl]-2-pyridinecarboxylic acid; treatment of conditions mediated by the action of PGE2 at EP1 receptors such as inflammatory pain, neuropathic pain or visceral pain |
| 09/25/2008 | US20080234320 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 09/25/2008 | US20080234305 Novel Tetrahydropyridine Derivatives |
| 09/25/2008 | US20080234273 Such as 3-{[4-(azetidin-1-ylcarbonyl)-2-chlorophenyl]oxy}-5-({(1S)-2-[(difluoromethyl)oxy]-1-methylethyl}oxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinases (Glk) |
| 09/25/2008 | US20080234271 Arylphenylamino- and Arylphenylether-Sulfide Derivatives, Useful For the Treatment of Inflammatory and Immune Diseases, and Pharmaceutical Compositions Containing Them |
| 09/25/2008 | US20080234254 anticarcinogenic agents for treating leukaemia, non-small cell lung cancers, colonic cancers, breast cancers, ovarian cancers, renal cancers and melanoma; in vivo hydrolysable ester or amide; N-(2-amino-phenyl)-4-[1-(3,4-dihydroisoquinolin-2(1H)-ylmethyl)vinyl]benzamide; solid phase synthesis |
| 09/25/2008 | CA2681516A1 Compounds useful as inhibitors of janus kinases |
| 09/25/2008 | CA2681015A1 Inhibitors of focal adhesion kinase |
| 09/24/2008 | EP1971577A2 Process for the preparation of unsymmetric bis(imino) compounds |
| 09/24/2008 | EP1971576A2 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 09/24/2008 | EP1408986B1 Proteomimetic compounds and methods |
| 09/24/2008 | EP1365762B1 Method for increasing leptin levels using nicotinic acid compounds |
| 09/24/2008 | CN101273048A Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes |
| 09/24/2008 | CN101273015A 3-cyclyl-2- (4-sulfamo yl-phenyl) -N-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
| 09/24/2008 | CN101270083A Method for preparing nicotinamide in high temperature liquid water medium with nicotinamine non-catalysis hydrolyzation |
| 09/24/2008 | CN101270082A Method for preparing 6-hydroxyl-3-cyanogen pyridine |
| 09/24/2008 | CN101270081A Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 09/24/2008 | CN101270080A Process for synthesizing azaperone |
| 09/24/2008 | CN101270079A Process for the separation of gaseous mix products in chloro-pyridine compounds production |
| 09/24/2008 | CN101270078A Metallic supermolecule compound for inhibiting telomere enzymatic activity, using method and uses thereof |
| 09/24/2008 | CN101270077A Comprehensive process for tail gas in glyphosate production |
| 09/24/2008 | CN101270069A Synthesis of taxol enhancers |
| 09/23/2008 | US7427618 e.g. 2-[3-(4-ethynylphenyl)ureido]-N-[4-(3-oxomorpholin-4-yl)phenyl]valeramide; anticoagulant, antitumor factor; thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty, claudicatio intermittens, or migraine |
| 09/23/2008 | CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof |
| 09/23/2008 | CA2335854C Improved process for the preparation of substituted pyridinecarboxylic acids |
| 09/23/2008 | CA2283643C Certain cyclic thio substituted acylaminoacid amide derivatives |
| 09/23/2008 | CA2253615C Process for preparing nicotinic acid |
| 09/18/2008 | WO2008112440A1 Piperazine and piperidine mglur5 potentiators |
| 09/18/2008 | WO2008111568A1 Modified metal complexes and use thereof |
| 09/18/2008 | WO2008111567A1 Metal complex |
| 09/18/2008 | WO2008111473A1 Glucokinase activator |
| 09/18/2008 | WO2008111450A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 09/18/2008 | WO2008111414A1 Catalyst composition, and process for production of cross-coupling compound using the same |
| 09/18/2008 | WO2008111300A1 Novel diamide derivative |
| 09/18/2008 | WO2008110357A1 Method for preparing a flupirtine maleate of a crystal modification b |
| 09/18/2008 | WO2008110278A2 Use of n2-phenylamidines as herbicides and herbicidal agents comprising the same |
| 09/18/2008 | WO2008109991A1 Inhibitors of carnitine palmitoyltransferase and treating cancer |
| 09/18/2008 | WO2008070496A3 N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| 09/18/2008 | US20080227984 Selective Oxidation of Organic Compounds |
| 09/18/2008 | US20080227981 Charge transport compositions and electronic devices made with such compositions |
| 09/18/2008 | US20080227858 as collagenase 1, 2 and 3, gelatinase A and B, stromelysin 1, 2 and 3, matrilysin, macrophage metalloelastase, enamelysin and membrane type 1, 2, 3 and 4 MMP; [(4'-Cyano-1,1'-biphenyl-4-yl)(methylsulfonyl)amino]acetic acid; antiinflammatory, anticarcinogenic agent, neurodegenerative diseases |
| 09/18/2008 | US20080227831 Contains N-methylnicotinamide; seaweed extracts; atherosclerosis |
| 09/18/2008 | US20080227828 Aryl Ureas With Angiogenisis Inhibiting Activity |
| 09/18/2008 | US20080227827 Compounds that abrogate dna damage induced cell cycle g2 checkpoint and/or augment anti-cancer activity of dna-damaging treatments |
| 09/18/2008 | US20080227787 4-tert-Butyl-N'-(2-(hydroxyimino)-1-phenylethylidene)benzohydrazide; treatment of inflammation |
| 09/18/2008 | US20080227776 inhibiting heme-induced lipid peroxidation; preventing isoprostane-mediated tissue damage |
| 09/18/2008 | US20080226716 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 09/18/2008 | US20080226581 Cosmetics, drugs; transfer optical properties; fluorescence, optical brighteners |
| 09/18/2008 | CA2680617A1 Use of n2-phenylamidines as herbicides |
| 09/18/2008 | CA2680366A1 Inhibitors of carnitine palmitoyltransferase and treating cancer |
| 09/18/2008 | CA2680244A1 Modified metal complex and use thereof |
| 09/18/2008 | CA2680240A1 Metal complex |
| 09/18/2008 | CA2679971A1 Glucokinase activator |
| 09/17/2008 | EP1970370A1 Amorphous form of 1,2-dihydropyridine compound |
| 09/17/2008 | EP1970062A1 Novel cxcr4 antagonist and use thereof |
| 09/17/2008 | EP1969651A1 Sensitizing complexes, their method of production, hybrid inorganic/ organic semiconductor material comprising them, and photovoltaic cell comprising this material |
| 09/17/2008 | EP1968941A1 Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (cetp) |
| 09/17/2008 | EP1968935A1 Substituted bis(hetero)aromatic n-ethylpropiolamides and use thereof for production of medicaments |
| 09/17/2008 | EP1968644A2 Polymer conjugates of glp-1 |
| 09/17/2008 | EP1968609A2 Pharmaceutical compositions and methods of use of highly lipophilic sulfhydryl compounds |
| 09/17/2008 | EP1824827B1 Method for producing onium salts comprising alkyl anions or aryl sulfonate anions or alkyl anions or aryl carboxylate anions having a low halide content |
| 09/17/2008 | EP1791825B1 Benzoyl-substituted serine amides |
| 09/17/2008 | EP1392639B1 Pyruvate derivatives |
| 09/17/2008 | EP1272827B1 Analyte detection |